SCRI-Oncology Hematology Care is a clinical research site located in Cincinnati, Ohio, United States 45242.
Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.
SCRI-Oncology Hematology Care has participated in 1 clinical trials.
Therapeutic areas: Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.
Sponsors: CTI BioPharma.
Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
SCRI-Oncology Hematology Care has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
SCRI-Oncology Hematology Care has 1 clinical trials on record. Their work covers Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis.
SCRI-Oncology Hematology Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.